Home » Topics » BioWorld Science

BioWorld Science
RSS

New EGFR-TKI to treat T790M-mediated resistant lung cancers

July 9, 2018

Universiteit Twente presents an ITGA5-binding peptide for pancreatic cancer

July 9, 2018

Taking the STING out of autoimmunity

July 9, 2018

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 6, 2018

Takeda advances acquisition of TiGenix

July 6, 2018

Enzyvant partners with Visikol on digital pathology assay to support RVT-802

July 6, 2018

Regulus Therapeutics announces corporate restructuring

July 6, 2018

MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy

July 6, 2018

Topline results from final analysis of phase II trial of BAN-2401 in Alzheimer's

July 6, 2018

Herantis initiates development program for noninvasive CDNF

July 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...